Contemporary management of atrial flutter

Circulation

Volumn 106, Issue 6, 2002, Pages 649-652

  Wellens, Hein J J ^a  

^a NONE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGITALIS; IBUTILIDE; SOTALOL;

ADULT; ANAMNESIS; CARDIOVERSION; CASE REPORT; CATHETER ABLATION; CLINICAL EXAMINATION; HEART ATRIUM FLUTTER; HUMAN; MALE; PRIORITY JOURNAL; REVIEW;

ANTI-ARRHYTHMIA AGENTS; ANTICOAGULANTS; ATRIAL FIBRILLATION; ATRIAL FLUTTER; CARDIAC PACING, ARTIFICIAL; CATHETER ABLATION; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; HUMANS; MALE; MIDDLE AGED; MODELS, CARDIOVASCULAR; TACHYCARDIA, SUPRAVENTRICULAR;

EID: 0037031317     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000027683.00417.9A     Document Type: Review

References (32)

1. The telecardiogramme
2. Observations upon a curious and not uncommon form of extreme acceleration of the auricle: Atrial flutter
3. Le flutter et ses limites
4. Entrainment and interruption of atrial flutter with atrial pacing: Studies in man following open heart surgery
5. Activation and entrainment mapping defines the tricuspid annulus as the anterior barrier in typical atrial flutter
6. Three-dimensional mapping of the common atrial flutter circuit in the right atrium
7. Right atrial flutter due to lower-loop re-entry: Mechanism and anatomic substrate
8. Hospitalization for arrhythmias in the United States: Importance of atrial fibrillation
9. Atrial flutter can be terminated by a class III antiarrhythmic drug, but not by a class IC drug
10. Characterization of low right atrial isthmus as the slow conduction zone and pharmacological target in typical atrial flutter
11. New anti-arrhythmic drugs for atrial flutter and atrial fibrillation: A conceptual breakthrough at last?
12. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation
13. Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation
14. Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: The symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study
15. Risks and benefits of antiarrhythmic therapy
16. New method for terminating cardiac arrhythmias: Use of synchronized capacitor discharge
17. Endocardial catheter fulguration for treatment of atrial flutter
18. Radiofrequency catheter ablation for the treatment of human type 1 atrial flutter: Identification of a critical zone in the reentrant circuit by endocardial mapping techniques
19. Radiofrequency ablation of the inferior vena cava-tricuspid valve isthmus in common atrial flutter
20. Radiofrequency ablation of type I atrial flutter: Prediction of late success by electrophysiological criteria
21. Acute and long-term effects of consecutive radiofrequency application on conduction properties of the subeustachian isthmus in type I atrial flutter
22. Long outcome of radiofrequency catheter ablation for typical atrial flutter: Risk of prediction of recurrent arrhythmias
23. Isoproterenol to evaluate resumption of conduction after right atrial isthmus ablation in type I atrial flutter
24. Marqueurs biochimiques de souffrance myocardique apres ablation de flutter auriculaire par radiofrequence de haute energie. Interet de la troponine I
25. Hybrid pharmacologic and ablative therapy: A novel and effective approach for the management of atrial fibrillation
26. Radiofrequency ablation of class IC atrial flutter in patients with resistant atrial fibrillation
27. The risk of atrial fibrillation following radiofrequency catheter ablation of atrial flutter
28. Atrial fibrillation after radiofrequency ablation of type I atrial flutter: Time to onset determinants and clinical course
29. Long term outcome of radiofrequency catheter ablation for typical atrial flutter: Risk prediction of recurrent arrhythmias
30. Effect of the right atrial isthmus ablation on the occurrence of atrial fibrillation. Observations in 4 patient groups having type I atrial flutter with or without associated atrial fibrillation
31. Delayed restoration of atrial function after conversion of atrial flutter by pacing or electrical cardioversion
32. Prospective randomized comparison of antiarrhythmic therapy versus first line radiofrequency ablation in patients with atrial flutter